The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction

Similar documents
Novel Targets for Treatment from the Dark Side of Dependence: Focus on the Brain Stress Systems

Alcohol, Stress and the Brain

Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives

What Can Science Contribute to the Treatment of Alcoholism?

Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

Overview. Unit 5: How do our choices change our brains?

AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS

Development of pharmacotherapies for drug addiction: a Rosetta Stone approach

DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse

The Neurobiology of Addiction. An Overview

The Addicted Brain. And what you can do

Neurobiology and Treatment of Alcohol Dependence. Nebraska MAT Training September 29, 2011

Drugs, The Brain, and Behavior

Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where

Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok

The Future of Treating Alcoholism: Framing the Key Research Questions

WHAT HAPPENS TO OUR BRAIN?

American Society of Addiction Medicine

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

Addiction Neurobiology

SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013

Alcohol Overuse and Abuse

NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH

Alcoholism, like addiction to other drugs, is a chronic, THE POTENTIAL OF NEUROSCIENCE TO INFORM TREATMENT. George F. Koob, Ph.D.

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

Introduction to Tolerance, Physical Dependence and Withdrawal

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

THE BRAIN & DRUGS. Nebraska Training on Substance Abuse Prevention

Contents. Acknowledgements List of abbreviations. xix xxi

The Science of Addiction:

Neurobiology of Reward and Addiction in the Vulnerable Brain. Alan I. Green, M.D. May 1, 2009

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Systematic Review of Treatment for Alcohol Dependence

7/29/2013. Pleasure Unwoven: An Adventure in Social Marketing. Choice vs. Disease. Kevin McCauley, MD Texas Behavioral Health Insistute July 2013

Tolerance and Dependence

Novel Pharmacological Treatments for Gambling Addiction Brian L. Odlaug, MPH

Beroendemekanismer- ett beroende som andra?

Chronic Stress, Drug Use, and Vulnerability to Addiction

Drugs of abuse (including alcohol)

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

Neurobiological and Neurobehavioral Mechanisms of Chronic Alcohol Drinking

The latest in addiction medicine: What every nurse needs to know

LESSON 5.7 WORKBOOK Is addiction a chronic disease?

substance abuse and addiction are complex phenomena

ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION. Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research

The Limbic System Theory of Addiction

Neuroadaptive mechanisms of addiction: studies on the extended amygdala

Understanding Addiction: The Intersection of Biology and Psychology

ASSIGNMENTS AND GRADING

1. According to recent US national estimates, which of the following substances is associated

Addiction Medicine 2014

Drug Addiction glutamate dysfunction, treatments, biomarkers. Peter Kalivas Department of Neurosciences Medical University of So Carolina Charleston

Necessary Steps to Prevent and Treat Substance Abuse

Understanding Addiction: Squirrel Logic

similar to other psychoactive drugs, drugs of abuse alter the

Drug Addiction, Dysregulation of Reward, and Allostasis George F. Koob, Ph.D., and Michel Le Moal, M.D., Ph.D.

Alcoholism In The Office SCOTT PAIST, III, M. D.

MOLECULAR AND CELLULAR BIOLOGY OF ADDICTION

NEUROPSYCHOPHARMACOLOGY 2000 VOL. 22, NO American College of Neuropsychopharmacology

Addiction, OCD, & riding a bike: how opiates control your brain

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

PERSPECTIVE. Is there a common molecular pathway for addiction? Eric J Nestler NEUROBIOLOGY OF ADDICTION

Pharmacogenetic approaches to the treatment of alcohol addiction

Sponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013

Dr. Joseph Frascella

How To Know If You Can Get Over Your Head With Exercise

Alchemy -Neuroscience of Alcoholism

The Neuropharmacology of Drugs of Abuse 3

Hilary J. Little, Ph.D.

The Developing Brain, Adolescence and Vulnerability to Drug Abuse

Addiction: The New Definition from the American Society of Addiction Medicine (ASAM)

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

NEUROBIOLOGY OF CANNABIS ADDICTION Part I

Brain and Anabolic steroids

Naltrexone and Alcoholism Treatment Test

Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky

4/13/ Actions to Overcome Addiction. John Fitzgerald, PhD, LPC, CAS. relationships

DrugFacts: Treatment Approaches for Drug Addiction

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

OVERVIEW OF MEDICATION ASSISTED TREATMENT

PERSPECTIVES. Opiate versus psychostimulant addiction: the differences do matter FOCUS ON ADDICTION

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation

The Science of Addiction and Its Effective Treatment

Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial

Martha Brewer, MS, LPC,LADC. Substance Abuse and Treatment

The addicted human brain: insights from imaging studies

fmri studies of addiction and relapse Rebecca Elliott Bill Deakin Anna Murphy Neuroscience and Psychiatry Unit

How To Understand How Alcohol Changes The Brain

Objectives. Addiction. Some terms. Some terms. Hierarchy of brain function 9/23/2011 PREGNANCY IN WOMEN WITH SUBSTANCE ABUSE: A DOORWAY TO CHANGE

Until now, all the chapters of this book have addressed how psychotropic drugs affect

Addictions. Assessment

Addictions: Why Don t They Just Quit?

Curriculum Vitae Cassandra Gipson Arizona State University Psychology Department

Neurobiology and pharmacology of psychostimulants

Addiction and the Brain's Pleasure Pathway: Beyond Willpower

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

The Hook, The Cage and the Empty Glass

Opioid Dependence: A Chronic, Relapsing Brain Disease

What Is Craving? Raymond F. Anton, M.D.

Transcription:

The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction George F. Koob, Ph.D. Professor and Chair Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla, California Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010) 217-238 Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. In: Spanagel R, Sommer W (eds) Behavioral Neurobiology of Alcohol Addiction (series title: Current Topics in Behavioral Neuroscience, 2013 Vol. 13), Springer, New York, pp. 3-30 Learning Objectives 1. Understand a conceptual framework of addiction that goes beyond the acute rewarding effects of drugs 2. Understand the neuroplasticity in the brain reward, stress systems and executive function systems associated with the transition to addiction 3. Understand how such knowledge may predict vulnerability and novel treatments for addiction 1

Stress and Reward: The Two Faces of Janus Bottom lines 1. Addiction is an incentive salience disorder 2. Addiction is a reward deficit disorder 3. Addiction is a stress surfeit disorder 4. Addiction is a self-regulation disorder 2

Addiction Addiction can be defined as a chronically relapsing disorder that is characterized by a compulsion to seek and take drug or stimulus, loss of control in limiting intake, and emergence of a negative emotional state (e.g. dysphoria, anxiety, irritability) when access to the drug or stimulus is prevented (here, defined as the dark side of addiction) Theoretical Framework Relating Addiction Cycle to Motivation for Drug Seeking From: Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. In: Spanagel R, Sommer W (eds) Behavioral Neurobiology of Alcohol Addiction (series title: Current Topics in Behavioral Neuroscience), Springer, New York, in press. 3

Positive and Negative Reinforcement- Definitions Positive Reinforcement defined as the process by which presentation of a stimulus (drug) increases the probability of a response (non dependent drug taking paradigms). Negative Reinforcement defined as a process by which removal of an aversive stimulus (negative emotional state of drug withdrawal) increases the probability of a response (dependence-induced drug taking) Stages of the Addiction Cycle 4

Non Drug Process Addiction Cycles Drug Addiction Compulsive Exercise Compulsive Shopping Compulsive Gambling Compulsive Eating Compulsive Sex Neurobiology of Addiction From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238 5

Binge-Intoxication Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010) 217-238 6

Effects of Cocaine and Amphetamine on Dopamine Synaptic Function Mesolimbic Dopamine System Mesolimbic dopamine system 1. Ventral tegmental area 2. Nucleus accumbens Nucleus Accumbens Ventral Tegmental Area (VTA) 7

Cocaine Self-Administration From: Caine SB, Lintz R and Koob GF. in Sahgal A (ed) Behavioural Neuroscience: A Practical Approach, vol. 2, IRL Press, Oxford, 1993, pp. 117-143. Pieter Bruegel 8

Opioid Peptide Reward System Enkephalin and endorphin reward system 1. Ventral tegmental area 2. Nucleus accumbens 3. Amygdala Nucleus Accumbens Amygdala Ventral Tegmental Area (VTA) Alcohol Consumption Induces Endogenous Opioid Release in the Human Nucleus Accumbens From: Mitchell JM, O Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL. Sci Transl Med, 2012, 4:116ra6. 9

Converging Acute Actions of Drugs of Abuse on the Ventral Tegmental Area and Nucleus Accumbens From: Nestler EJ, Nat Neurosci, 2005, 8:1445-1449. Neurocircuitry of Incentive Salience The Ventral to Dorsal Striatal Shift: Ascending Spirals of VTA/Nigra-Striatal pathways goal-directed drug seeking & taking pavlovian conditioning drug seeking & taking habits vulnerability abstinence/ relapse compulsive drug seeking Everitt & Robbins 2005 Ikemoto 2007 - similar organization in rat brain Haber et al. 2000 10

template "Absinthe Drinker" Pablo Picasso (1910) Withdrawal-Negative Affect Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology Reviews 35 (2010) 217-238 11

Standard Pattern of Affective Dynamics Produced by Novel and Repeated Unconditioned Stimulus or Opponent Process: What Goes Up Must Come Down From: Solomon RL, American Psychologist, 1980, 35:691-712. Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Positive Hedonic Effects Dopamine Opioid peptides Serotonin GABA Negative Hedonic Effects of Withdrawal Dopamine dysphoria Opioid peptides... pain Serotonin dysphoria GABA anxiety, panic attacks 12

Decreased Dopamine D 2 Receptor Activity in a Cocaine Abuser From: Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey S and Wolf AP, Synapse, 1993, 14:169-177. CNS Actions of Corticotropin-Releasing Factor (CRF) 13

Rodent Model of Excessive Drinking During Withdrawal Self-administration training Dependence induction Withdrawal from alcohol vapors Negative emotional state: Anxiety-like behavior Reward threshold deficits Increased CRF release in the extended amygdala Sweetened solution fading used to train animals to lever press for: 10%w/v EtOH vs Water Chronic intermittent alcohol vapors (4+ wks) Target blood alcohol levels (BALs): 0.125-0.250 g% Excessive drinking: 2-3 fold higher alcohol intake Increased progressive ratio breakpoints Relapse following prolonged abstinence Methods from: Roberts AJ, Cole M and Koob GF, Alcohol Clin Exp Res, 1996, 20:1289-1298. Roberts AJ, Heyser CJ, Cole M, Griffin P and Koob GF, Neuropsychopharmacology, 2000, 22:581-584. O Dell LE, Roberts AJ, Smith RT and Koob GF, Alcohol Clin Exp Res, 2004, 28:1676-1682. Summary of Drugs of Abuse Interactions with Corticotropin-Releasing Factor Systems CRF Antagonist Effects Withdrawal-induced changes in extracellular CRF in CeA Withdrawal-induced anxiety-like or aversive responses Baseline selfadministration or place preference Dependence-induced increases in selfadministration Stress-induced reinstatement Modified from: Swanson LW, Sawchenko PE, Rivier J and Vale W, Neuroendocrinology, 1983, 36:165-186. Koob GF, Neuron, 59:11-34 14

Anti-Reward Transmitters Implicated in the Motivational Effects of Drugs of Abuse Dynorphin dysphoria CRF stress Norepinephrine stress Non-dependent Dependent Positive Reinforcement Negative Reinforcement 15

Neurobiology of Addiction: Preoccupation- Anticipation ( Craving ) Stage From: Koob, G. F. and Volkow. N. D. Neurocircuitry of Addiction, Neuropsychopharmacology reviews 35 (2010) 217-238 Loss of Control Over Intake Self-medication Cause Neuron/oligodendrocyte death VTA CRF Neurons? PFC DA/NE? Initial intake PFC CRF/GABA interneurons Withdrawal 16

Medications Development- A Rosetta Stone Approach From: Koob GF, Lloyd GK, Mason BJ. Nat Rev Drug Discovery, 2009, 8:500-515. Future Targets for Medications Development Derived from Preclinical Basic Research Class Dopamine receptor partial agonists Target D 2 receptor partial agonist (aripiprazole) D 3 receptor partial agonist Modulators of g-aminobutyric acid Gabapentin Modulators of brain stress systems CRF 1 receptor antagonist Dynorphin antagonist Neurokinin-1 receptor antagonist Modulators of glutamate AMPA receptor antagonist NMDA receptor antagonist Metabotropic glutamate receptor agonist Glutamate-5 receptor antagonist Topiramate From: Koob GF, Lloyd GK, Mason BJ. Nat Rev Drug Discov, 2009, 8:500-515. 17

Bottom lines 1. Addiction is a facilitation of incentive salience - compulsive drug taking is associated with engagement of associative (stimulus response) mechanisms involving cortico-striatal-pallidal-thalamic loops that converge in the basal ganglia 2, Addiction is a reward deficit disorder- all drugs of abuse compromise reward function and decrease dopamine activity 3. Addiction is a stress surfeit disorder- all drugs of abuse sensitize brain stress systems such as CRF 4. Addiction is an executive system disorder- all drugs of abuse compromise frontal cortical executive function which disinhibits impulsivity and disinhbits the brain stress systems Learning Objectives 1. Understand a conceptual framework of addiction that goes beyond the acute rewarding effects of drugs 2. Understand the neuroplasticity in the brain reward, stress systems and executive function systems associated with the transition to addiction 3. Understand how such knowledge may predict vulnerability and novel treatments for addiction 18

Neurobiology of Drug Addiction Koob Laboratory Post-Doctoral Fellows Cindy Funk Brendan Walker Tom Greenwell Sandy Ghozland Chitra Mandyam Dong Ji Candice Contet Laura Orio Kaushik Misra Nick Gilpin Michel Verheij Sunmee Wee Scott Edwards Leandro Vendruscolo Tim Whitfield Joel Schossberg Ami Cohen Carrie Wade Brooke Schmeichel Visiting Professors Choon-Gon Jang Charles Heyser Special Mention Olivier George Prefrontal Cortex, c-fos, CRF, and executive function Support from: Ph.D. Students Paula Park Cara Buck Administrative Assistants Lisa Maturin Mellany Santos Marisa Gallego Staff Scientists Heather Richardson Olivier George Senior Research Assistants Mike Arends Elena Crawford Robert Lintz National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases Pearson Center for Alcoholism and Addiction Research 19